IMV
$2.889876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.08 (2.85%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours
Why Robinhood?
You can buy or sell IMV and other stocks, options, ETFs, and crypto commission-free!
About IMV
IMV, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Read More The company was founded by Warwick Kimmins and Brian E. Lowe on March 28, 2000 and is headquartered in Dartmouth, Canada.
CEO
Employees
—
Headquarters
Dartmouth, Nova Scotia
Founded
2000
Market Cap
141.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.77K
High Today
$2.95
Low Today
$2.84
Open Price
$2.90
Volume
3.42K
52 Week High
$7.07
52 Week Low
$2.25
Collections
IMV News
Price Paid on Robinhood
29% Lower
Right Now
52 Week Low
$2.90
Average Price Paid
$4.04
52 Week High
$7.21
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
IMV Earnings
-$0.13
-$0.11
-$0.10
-$0.08
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, Pre-Market